CH566784A5 - - Google Patents

Info

Publication number
CH566784A5
CH566784A5 CH633872A CH633872A CH566784A5 CH 566784 A5 CH566784 A5 CH 566784A5 CH 633872 A CH633872 A CH 633872A CH 633872 A CH633872 A CH 633872A CH 566784 A5 CH566784 A5 CH 566784A5
Authority
CH
Switzerland
Application number
CH633872A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH566784A5 publication Critical patent/CH566784A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH633872A 1971-04-30 1972-04-28 CH566784A5 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
CH566784A5 true CH566784A5 (cs) 1975-09-30

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
CH633872A CH566784A5 (cs) 1971-04-30 1972-04-28

Country Status (23)

Country Link
US (1) US3758683A (cs)
JP (1) JPS5735185B1 (cs)
BE (1) BE782651A (cs)
CA (1) CA976085A (cs)
CH (1) CH566784A5 (cs)
CS (1) CS209458B2 (cs)
DD (1) DD100708A5 (cs)
DE (1) DE2219635C3 (cs)
DK (1) DK131760C (cs)
ES (1) ES402176A1 (cs)
FI (1) FI49773C (cs)
FR (1) FR2134658B1 (cs)
GB (1) GB1385086A (cs)
HU (1) HU166989B (cs)
IL (1) IL39181A (cs)
NL (1) NL178258C (cs)
NO (1) NO137178C (cs)
PL (1) PL86966B1 (cs)
RO (1) RO64387A (cs)
SE (1) SE378066B (cs)
SU (1) SU508162A3 (cs)
YU (1) YU36155B (cs)
ZA (1) ZA722243B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
JP2606915B2 (ja) * 1987-02-25 1997-05-07 ノボ ノルディスク アクティーゼルスカブ 新規インシュリン誘導体
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
CR20170369A (es) 2008-10-17 2017-11-01 Sanofi Aventis Deutschland COMBINACIÓN DE UNA INSULINA Y UN AGONISTA DE GLP-1 (Divisional 2011-0188)
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
PL2498802T3 (pl) 2009-11-13 2015-06-30 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
EP2750699B1 (en) 2011-08-29 2015-07-22 Sanofi-Aventis Deutschland GmbH Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
RS65380B1 (sr) 2017-08-24 2024-04-30 Novo Nordisk As Glp-1 kompozicije i njihova upotreba
IL294520A (en) 2020-02-18 2022-09-01 Novo Nordisk As Pharmaceutical formulations
CN118949061A (zh) * 2023-08-07 2024-11-15 浙江大学 一种糖响应鱼精蛋白胰岛素及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
CA976085A (en) 1975-10-14
YU36155B (en) 1982-02-25
DK131760C (da) 1976-02-02
RO64387A (fr) 1979-07-15
NL178258B (nl) 1985-09-16
DK131760B (da) 1975-09-01
NL7205865A (cs) 1972-11-01
DD100708A5 (cs) 1973-10-05
HU166989B (cs) 1975-07-28
DE2219635B2 (de) 1980-11-27
GB1385086A (en) 1975-02-26
ZA722243B (en) 1973-11-28
PL86966B1 (cs) 1976-06-30
FI49773C (fi) 1975-10-10
ES402176A1 (es) 1975-03-01
FR2134658A1 (cs) 1972-12-08
NO137178C (no) 1978-01-18
BE782651A (fr) 1972-10-26
DE2219635C3 (de) 1981-10-15
CS209458B2 (en) 1981-12-31
YU114272A (en) 1981-06-30
US3758683A (en) 1973-09-11
NL178258C (nl) 1986-02-17
JPS5735185B1 (cs) 1982-07-27
SU508162A3 (ru) 1976-03-25
NO137178B (no) 1977-10-10
IL39181A (en) 1974-09-10
FI49773B (cs) 1975-06-30
SE378066B (cs) 1975-08-18
DE2219635A1 (de) 1972-11-09
FR2134658B1 (cs) 1975-10-17
IL39181A0 (en) 1972-06-28

Similar Documents

Publication Publication Date Title
ATA136472A (cs)
AR196074A1 (cs)
AU2658571A (cs)
AU2691671A (cs)
AU2952271A (cs)
AU2941471A (cs)
AU2894671A (cs)
AU2742671A (cs)
AU2726271A (cs)
AU2485671A (cs)
AU2684071A (cs)
AU3005371A (cs)
AU2564071A (cs)
AU2473671A (cs)
AU2836771A (cs)
AU3038671A (cs)
AU2503871A (cs)
AU3025871A (cs)
AU2577671A (cs)
AU2588771A (cs)
AU2654071A (cs)
AR199640Q (cs)
AU2669471A (cs)
AU2456871A (cs)
AU2684171A (cs)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased